Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Insider-Trading Case Puts Focus on Key FDA System
WSJ Online
Thursday, March 31, 2011 - 10:46am
tags:
FDA, insider trading
Valeant may up Cephalon offer if given books
Winnipeg Free Press, Canada
Thursday, March 31, 2011 - 10:45am
tags:
Cephalon, Valeant Pharmaceuticals, M&A
NeurogesX Q4 loss more than doubles
Bizjournals.com
Thursday, March 31, 2011 - 10:43am
tags:
NeurogesX, earnings
Allos Therapeutics Evenly Poised
Yahoo/Zacks.com
Thursday, March 31, 2011 - 10:43am
tags:
Allos, Celgene, Folotyn, T-cell lymphoma
Ahead of the Bell: Analyst lowers Bristol-Myers
Yahoo/AP
Thursday, March 31, 2011 - 10:41am
tags:
Bristol-Myers Squibb, downgrades
Medicare to pay for $93,000 prostate cancer drug Provenge
Yahoo/AP
Thursday, March 31, 2011 - 9:58am
tags:
Medicare, prostate cancer, Dendreon, Provenge
J&J Reorganizes McNeil Consumer Unit After Year of Recalls
Bloomberg
Thursday, March 31, 2011 - 9:58am
tags:
reorganization, recalls, JNJ, McNeil
Pfizer Collaboration With Apple/FDA: A Strategic Shift to Scientific Content in Marketing
Seeking Alpha
Thursday, March 31, 2011 - 9:32am
tags:
Apple/FDA, Pfizer
[video] Momentum BioPharmaceutical Play: Stocks Under $10
TheStreet.com
Thursday, March 31, 2011 - 9:31am
tags:
Cornerstone Therapeutics
Abbott Ordered to Pay Glaxo $3.5 Million in HIV Drug Suit
Bloomberg
Thursday, March 31, 2011 - 9:27am
tags:
GSK, Abbott Laboratories, HIV, settlements, Norvir
Raptor Pharmaceuticals: Pipeline Worth a Closer Look
Seeking Alpha
Thursday, March 31, 2011 - 9:26am
tags:
Raptor Pharmaceuticals, DR Cysteamine, nephropathic cystinosis
Merck KGaA tries again on Erbitux for lung cancer
Fierce Pharma
Wednesday, March 30, 2011 - 4:47pm
tags:
Merck KGaA, lung cancer, Erbitux
Amgen's Long Shot Comes Up Short
Motley Fool
Wednesday, March 30, 2011 - 4:45pm
tags:
Amgen, motesanib, Takeda, lung cancer, Taxol, Bristol-Myers Squibb
Uncovering Hidden Opportunity in Medivation's Alzheimer's Drug
Seeking Alpha
Wednesday, March 30, 2011 - 4:44pm
tags:
Medivation, Alzheimer's disease
Merck, Novartis Blood Cancer Drugs May Shrink Child Tumors, Study Finds
Bloomberg
Wednesday, March 30, 2011 - 12:44pm
tags:
Novartis, Merck, HDAC inhibitors, LBH589, Zolinza
Cephalon’s Shares Surge Above Offer Price
NY Times, NY
Wednesday, March 30, 2011 - 12:42pm
tags:
M&A, Cephalon, Valeant Pharmaceuticals
FDA thwarts KV's over-the-top pricing on Makena
Fierce Pharma
Wednesday, March 30, 2011 - 11:45am
tags:
FDA, KV Pharmaceutical, Makena, premature birth
GSK partner holds off generic rival for Lovaza
Fierce Pharma
Wednesday, March 30, 2011 - 11:43am
tags:
GSK, Lovaza, generics, Pronova BioPharma ASA
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom
In-Pharm
Wednesday, March 30, 2011 - 11:41am
tags:
Roche, M&A, Novartis
Cephalon Stock Rises Above Valeant Takeover Bid of $73 a Share
Bloomberg
Wednesday, March 30, 2011 - 11:39am
tags:
M&A, Valeant Pharmaceuticals, Cephalon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.